Research Antibodies & Reagents
Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the research antibodies & reagents market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[198 Pages Report] The Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030.

Research antibodies are proteins produced by the body's immune system to respond to harmful substances or antigens, such as bacteria and viruses. Scientists synthetically produce these antibodies in laboratories for research purposes. Laboratory-produced research antibodies bind to specific antigens, thus marking them for identification, detection, or neutralization. These antibodies are integral in many research operations, including enzyme-linked immunosorbent assay (ELISA), immunohistochemistry, flow cytometry, western blotting, and immunofluorescence. Reagents in the context of scientific research refer to any substance that is utilized to induce a chemical reaction or to experiment if a reaction occurs. The wide array of research reagents entails enzymes, solvents, catalysts, buffers, and more, each with distinct uses and applications. Reagents play critical roles in molecular biology research, facilitating processes such as DNA replication, RNA transcription, protein synthesis, and cell lysis. The research antibodies and reagents market refers to the products, tools, and services researchers use in various fields such as healthcare, biotechnology, pharmaceuticals, and academic institutions to study diverse biological processes. Several factors contribute to the growth of the research antibodies and reagents market, including increasing research activities by pharmaceutical and biopharmaceutical companies and the rising popularity of proteomics and genomics research. The emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics supports this upward market growth. However, the growth of the research antibodies and reagents market is facing certain challenges, including the high cost of antibody development processes, and quality concerns, and a lack of reproducible results of research antibodies & reagents. On the other hand, increasing R&D in research antibodies & reagents and rising focus on discovering novel biomarkers present potential opportunities for the market to grow in the coming years.

Regional Insights

Americas represents a highly developing landscape characterized by substantial investments in R&D activities by pharmaceutical and biotechnological companies and the presence of multiple research institutes. Additionally, the recent increase in patented scientific research augments the demand for research antibodies & reagents in the Americas. Significant governmental initiatives and investments to expand biotechnology research and development with advanced research equipment and tools are expected to foster the growth of the research antibodies & reagents market in Asia-Pacific. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The research antibodies & reagents market witnessed substantial growth in Europe, the Middle East, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

Research Antibodies & Reagents Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Research Antibodies & Reagents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increasing research activities by pharmaceutical and biopharmaceutical companies
    • Rising popularity of proteomics and genomics research
    • Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
  • Market Restraints
    • High cost of antibody development processes
  • Market Opportunities
    • Increasing R&D in research antibodies & reagents
    • Rising focus on discovering novel biomarkers
  • Market Challenges
    • Quality concerns and a lack of reproducible results of research antibodies & reagents
Market Segmentation Analysis
  • Product: Increasing popularity of antibodies for detection and quantification of target proteins

    Antibodies, specialist proteins that detect foreign bodies such as bacteria and viruses, are fundamental in several immunoassay applications such as western blotting and flow cytometry. There are different types, such as monoclonal antibodies (mAbs), which are identical because they are produced by a kind of immune cell, all clones of a single parent cell, ensuring uniformity and high specificity. Polyclonal antibodies (pAbs) are derived from different B cell lines, resulting in a mixture of antibodies that identify distinct epitopes on the same antigen. Recombinant antibodies are derived from a broad mix of parental antibodies and are usually engineered to have a desired specificity. Reagents are crucial for biochemical assays, genetic processing, and other molecular biology techniques. The reagents group includes many elements, such as buffers, which are responsible for maintaining the pH of a solution, making them vital for many biological processes. Enzymes, proteins that speed up chemical reactions, are instrumental in breaking down, combining, or changing certain chemicals in the body. Fixatives preserve tissues from decay, which is beneficial in histology and pathology labs. Media & sera refer to the sustenance provided to cells under cell culture; the 'media' offer essential nutrients while 'sera' provide additional growth factors that help cells multiply. Probes are utilized predominantly in molecular biology and biochemistry to detect, identify, and isolate specific sequences in DNA or RNA. Solvents are substances, usually a liquid, used to dissolve a solute, resulting in a solution. Stains & dyes are chemicals used to enhance the contrast in the microscopic image or to make a microscopic image visible for observation. While both product segments occupy an essential position in the research context, they cater to different research needs. Antibodies lend themselves to the detection and quantification of target proteins, while reagents facilitate broader laboratory techniques, including DNA, RNA manipulation, biochemical reactions, and cell cultures.

  • Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping

    Enzyme-linked Immunosorbent Assay (ELISA) is a procedure for quantifying and detecting specific antigens or antibodies in biological samples. ELISA is an advantageous technology due to its high sensitivity, specificity, and low cost, which suits research, diagnostic, and quality control applications in various fields, such as infectious disease testing and drug monitoring. Flow cytometry is a laser-based technology that permits concurrent measurement of multiple parameters on individual cells in a fast and efficient manner. It is commonly used for cell counting, sorting, immunophenotyping, and biomarker detection in immunology, oncology, hematology, and stem cell research. Immunofluorescence is a microscopy-based technique that uses fluorescently labeled antibodies to detect specific proteins or other biomolecules in cells and tissues. It offers high sensitivity, specificity, and spatial resolution for studying protein expression, localization, and interaction in fixed or live samples. Immunohistochemistry is an essential method for localizing proteins within tissue sections using specific antibodies conjugated with chromogenic or fluorescent markers. IHC is widely used in pathological diagnosis, research on cellular processes, and drug discovery efforts. Immunoprecipitation is a powerful method used to isolate target proteins from complex mixtures by using specific antibodies immobilized on solid support beads. IP can help study protein-protein interactions, post-translational modifications, and protein-nucleic acid interactions. Western blotting is a technique for catching specific proteins in complex samples based on their molecular weight using gel electrophoresis followed by antibody-based detection on membranes. It serves as a tool for protein expression analysis, validation of gene silencing or overexpression experiments, and diagnostic evaluations.

  • Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases

    Immunology-based antibodies and reagents are paramount in allergy and asthma, autoimmune disease, and transplantation. In fighting infectious diseases, research antibodies are key tools in the identification and detection of pathogens by utilizing research antibodies to demonstrate the presence of specific antigens or antibodies in a patient's serum. Additionally, reagents are vital in cultivating viruses for vaccines and antiviral drug testing. Neurobiology needs antibodies and reagents, with research focusing on neurodegenerative diseases and brain injuries. Research antibodies have revolutionized the field of oncology and are widely employed in the targeted therapy of cancer, where monoclonal antibodies can bind to cancer cells, hindering their growth and proliferation. Their utility in immunohistochemistry allows for the detailed subtype classification of tumors. In the area of stem cell research, antibodies play an indispensable role in the determination of stem cell potency and differentiation status. Reagents are heavily used in cell culture to help the growth and differentiation of stem cells. Stem cell research has seen steady advancements in regenerative medicine and therapeutic cloning, largely fueled by the evolving applications of research antibodies and reagents.

  • Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets

    In drug development, research antibodies and reagents are crucial in target identification, validation, and pre-clinical studies. They facilitate the identification of protein targets, accelerate therapeutic antibody generation, and support the evaluation of drug efficacy and safety. Genomics research relies on high-quality antibodies and reagents for techniques such as gene expression analysis, chromatin immunoprecipitation (ChIP), DNA methylation studies, and CRISPR/Cas9 gene editing. These tools help identify genes involved in diseases and enable a deeper understanding of genetic mechanisms. In proteomics research, antibodies are indispensable tools for protein detection and quantification through methods such as western blotting, enzyme-linked immunosorbent assay (ELISA), mass spectrometry (MS), or protein microarrays. High-performance research antibodies enable investigators to study post-translational modifications (PTMs), protein-protein interactions (PPIs), and cellular localization of proteins accurately. Research antibodies and reagents remain indispensable tools within life science applications driven by ongoing innovations in synthetic biology or CRISPR/Cas9 gene editing techniques. These advancements continue to shape our understanding of biology and disease mechanisms with unprecedented precision.

  • End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies

    Academic & research institutions predominantly require antibodies & reagents for various types of biomedical and clinical research. Entities such as universities, medical schools, and governed research institutes prefer comprehensive kits and highly specific antibodies to facilitate research in immunology, cell biology, molecular biology, and biochemistry. Contract research organizations (CROs) increasingly use antibodies & reagents in their pre-clinical and clinical research. Primarily, CROs focus on high sensitivity and reliability in their assays and prefer reagents that optimize the efficiency of high-throughput screening. Pharmaceutical and biotechnology companies utilize antibodies and reagents extensively in drug development and therapeutic interventions.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Research Antibodies & Reagents Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Research Antibodies & Reagents Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Research Antibodies & Reagents Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Research Antibodies & Reagents Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Research Antibodies & Reagents Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Research Antibodies & Reagents Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Research Antibodies & Reagents Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Research Antibodies & Reagents Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Research Antibodies & Reagents Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Research Antibodies & Reagents Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

The Research Antibodies & Reagents Market Research Report by 360iResearch has been a game-changer for us. Before leveraging this report, we faced significant challenges in identifying growth opportunities and optimizing our R&D efforts. The valuable insights and actionable strategies it provided have enabled us to increase our research and development in antibodies and reagents. Thanks to this comprehensive report, we have streamlined our operations, leading to more targeted and effective research. We are thoroughly satisfied with the positive impact it has had on our organization.
Dovetail Genomics LLC
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Research Antibodies & Reagents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Research Antibodies & Reagents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation

    GenScript Biotech Corporation has expanded its IVT mRNA synthesis portfolio by offering customized circular RNA (circRNA) and lipid nanoparticles (LNPs) formulation services. GenScript's comprehensive turnkey solution ensures that scientists receive full scientific support, from sequence design to vial delivery. [Published On: 2023-09-18]

  • Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes

    Bio-Rad Laboratories, Inc. has launched the 29th StarBright Dye, called StarBright Red 670. Additionally, they have expanded their current range by introducing 29 more antibodies conjugated to StarBright Blue 700 and StarBright Violet 610 Dyes. The newly added targets include human and mouse antibody markers and cow, dog, and pig targets for veterinary immunology research. [Published On: 2023-09-05]

  • Danaher to Acquire Abcam plc

    Danaher Corporation has acquired Abcam plc in a cash transaction valued at approximately USD 5.7 billion. This strategic move aims to leverage Abcam plc's expertise in mapping complex diseases and accelerate the drug discovery process. This acquisition marks a significant milestone in research antibodies and reagents, ensuring the continued availability of high-quality products and services to researchers worldwide. [Published On: 2023-08-28]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Research Antibodies & Reagents Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

The 'Rising popularity of proteomics and genomics research' report from 360iResearch has been a game-changer for us. Before using the report, we struggled to stay ahead in the rapidly evolving research fields. The actionable strategies and deep insights provided by the report helped us navigate complex market dynamics. We particularly benefited from the detailed analysis of emerging trends and competitive landscape. This valuable resource has significantly optimized our operations and strategic planning. Our satisfaction with the positive impact on our organization is immense.
Tosoh Corporation
Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Dovetail Genomics LLC, Tosoh Corporation, Randox Laboratories Ltd., Enzo Life Sciences, Inc., GenScript Biotech Corporation, BASF SE, Bio-Rad Laboratories, Inc., Alpha Teknova, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ImmunoPrecise Antibodies Ltd., Charles River Laboratories International, Inc., LifeSpan BioSciences, Inc., Cell Signaling Technology, Inc., Abbott Laboratories, bioMérieux S.A., Atlas Antibodies AB, FUJIFILM Holdings Corporation, Santa Cruz Biotechnology, Inc., QIAGEN N.V., Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific, Inc., Lonza Group Ltd., Sino Biological, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Rockland Immunochemicals, Inc., Avantor, Inc., Danaher Corporation, Leinco Technologies, Inc., Agilent Technologies Inc., Bio-Techne Corporation, Honeywell International Inc., Illumia, Inc., Omega Bio-tek, Inc., and LobaChemie Pvt. Ltd..

Research Antibodies & Reagents Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Antibodies
      • Monoclonal Antibodies
      • Polyclonal Antibodies
      • Recombinant Antibodies
    • Reagent
      • Buffers
      • Enzymes
      • Fixatives
      • Media & Sera
      • Probes
      • Solvents
      • Stains & Dyes
  • Technology
    • Enzyme-linked Immunosorbent Assay
    • Flow Cytometry
    • Immunofluorescence
    • Immunohistochemistry
    • Immunoprecipitation
    • Western Blotting
  • Indication
    • Immunology
    • Infectious Diseases
    • Neurobiology
    • Oncology
    • Stem Cells
  • Application
    • Drug Development
    • Genomics
    • Proteomics
  • End User
    • Academic & Research Institutions
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Before discovering the Research Antibodies & Reagents Market Research Report by 360iResearch, we faced numerous challenges in navigating the emerging trends in personalized medicine and protein therapeutics. The report provided us with invaluable insights and actionable strategies that have significantly enhanced our operations. Thanks to its thorough analysis, we're now more adept at identifying growth opportunities and staying ahead of market shifts. We highly recommend this report for any organization looking to excel in the Research Antibodies & Reagents sector.
Randox Laboratories Ltd.
This research report offers invaluable insights into various crucial aspects of the Research Antibodies & Reagents Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Research Antibodies & Reagents Market, by Product
  7. Research Antibodies & Reagents Market, by Technology
  8. Research Antibodies & Reagents Market, by Indication
  9. Research Antibodies & Reagents Market, by Application
  10. Research Antibodies & Reagents Market, by End User
  11. Americas Research Antibodies & Reagents Market
  12. Asia-Pacific Research Antibodies & Reagents Market
  13. Europe, Middle East & Africa Research Antibodies & Reagents Market
  14. Competitive Landscape
  15. Competitive Portfolio
  16. List of Figures [Total: 26]
  17. List of Tables [Total: 662]
  18. List of Companies Mentioned [Total: 37]
Frequently Asked Questions
  1. How big is the Research Antibodies & Reagents Market?
    Ans. The Global Research Antibodies & Reagents Market size was estimated at USD 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024.
  2. What is the Research Antibodies & Reagents Market growth?
    Ans. The Global Research Antibodies & Reagents Market to grow USD 36.62 billion by 2030, at a CAGR of 12.02%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.